| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930511 | Cytotherapy | 2015 | 12 Pages |
Abstract
EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Justyna Nowakowska, Claudia Stuehler, Adrian Egli, Manuel Battegay, Georg Rauser, Glenn Robert Bantug, Christian Brander, Christoph Hess, Nina Khanna,